This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Isogenis, Inc.. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: The Innovative Mind of William J. Maslanik
Introduction
William J. Maslanik, an esteemed inventor located in Denver, CO, has made remarkable contributions to the field of gene therapy and adenoviral vectors. With three patents to his name, Maslanik's work is at the forefront of innovative medical technology, aimed at advancing therapeutic solutions for various diseases.
Latest Patents
Maslanik's latest patents focus on the construction of fully-deleted adenovirus-based gene delivery vectors. These inventions emphasize the packaging of adenoviral vectors without the need for helper adenovirus. The disclosed embodiments enhance gene therapy applications, allowing for improved gene and protein expression, vaccine development, and immunosuppressive therapies for allogeneic transplantation. One notable method outlined includes providing an adenovirus packaging cell line, transfecting it with a fully-deleted adenoviral vector construct, and subsequently encapsulating the vector independently. This innovative approach addresses the treatment of various conditions, diseases, or disorders by efficiently delivering genetic therapies.
Career Highlights
William J. Maslanik has established himself as a leading figure in his field through his exemplary work at Isogenis, Inc. His focus on gene delivery systems has been pivotal in enhancing therapeutic practices within the biotechnology sector. Maslanik's inventive spirit and rigorous research methodologies have propelled advancements in medical science.
Collaborations
Throughout his career, Maslanik has collaborated with notable individuals such as Miles B. Brennan and Erin K. Spiegel. These partnerships have fostered a creative environment that spurs innovation and problem-solving in the development of gene therapies and related technologies.
Conclusion
In conclusion, William J. Maslanik is a distinguished inventor whose work on adenovirus-based gene delivery systems plays a crucial role in modern medicine. With his innovative approach and numerous patents, Maslanik's contributions are set to impact the future of gene therapy and therapeutic development significantly. His ongoing collaboration with colleagues further exemplifies the dynamic and collaborative nature of scientific advancements in this field.